ReviewPediatric health, medicine and therapeutics2021
Hemolytic Disease of the Newborn: A Review of Current Trends and Prospects.
Review in Pediatric health, medicine and therapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05842109 (Clinical Value of ETCOc in the Diagnosis and Treatment of ABO Hemolytic Disease of the Newborn), which is not on this map. Cited by 28 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Clinical Value of ETCOc in the Diagnosis and Treatment of ABO Hemolytic Disease of the Newborn
Who cites it
28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 64 citations in OpenAlex.
- Efficacy and safety of different doses of intravenous immunoglobulin combined with phototherapy in neonatal hemolytic disease: a systematic review and meta-analysis.European journal of pediatrics · 2026Pooled it
- Patient experience and burden of haemolytic disease of the foetus and newborn: a systematic review.BMC pregnancy and childbirth · 2025Pooled it
- Global, Regional and National Burden of Hemolytic Disease and Other Neonatal Jaundice, 1980/90-2021, and Projections to 2050: A Global Burden of Disease Study 2021.Health science reports · 2026Article
- Improving In Vitro Antibody Production Using Synthetic Peptide Derived from RhD Loops.Applied biochemistry and biotechnology · 2026Article
- Adverse perinatal outcomes indicative of RhD-mediated hemolytic disease of the fetus and newborn in Eastern Ethiopia: evidence of maternal health inequity in a multicenter cohort study.AJOG global reports · 2026Article
- Challenges in interpreting leukocyte and nucleated red blood cell counts in neonatal hemolytic disease: A case report on hematology analyser performance.Journal of medical biochemistry · 2026Article
- Immunohaematological Testing, Monitoring, and Treatment of Haemolytic Disease of the Newborn: Where are we in this Field after 25 Years?Journal of mother and child · 2026Article
- Identification and analysis of a novel A allele with a c.565A > G variant on the ABO*A1.02 allele leading to subtype A: A case report.Medicine · 2025Article
- Severe Hemolytic Disease of the Fetus Treated with Serial Intrauterine Transfusions: A Case Report and Review of Current Management.Life (Basel, Switzerland) · 2025Article
- Hemolytic Disease of the Fetus and Newborn in an Integrated Health Care System.American journal of perinatology · 2025Article
- Comparison of demographic characteristics and haematological parameters in newborns with and without haemolytic disease due to ABO incompatibility.BMC pediatrics · 2025Article
- Neonatal Hemolytic Jaundice: Causes, Diagnostic Approach, and Management.Children (Basel, Switzerland) · 2025Review
- Several features of newborns following intrauterine intravascular blood transfusion for fetal hemolytic disease caused by anti-D alloimmunization.Transfusion · 2025Article
- Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2025Review
- Research progress in RBC alloimmunization.Frontiers in immunology · 2025Review
- Analysis of pregnancy and neonatal outcomes in 100 pregnant women with Rh-negative blood type.BMC pregnancy and childbirth · 2024Article
- Pregnant women's knowledge and clinical management of hemolytic disease of the fetus and newborn in Pará, Brazil.Hematology, transfusion and cell therapy · 2024Article
- The Diagnostic Potential of the L Score for ABO Hemolytic Disease of the Newborn: Insights from a Cross-Sectional Study.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2024Article
- Differences in maternal-newborn ABO blood groups and risk of serious infant infection.QJM : monthly journal of the Association of Physicians · 2024Article
- Is Feto-Maternal Transfusion after Cesarean Delivery Different in Singleton and Twin Pregnancy?Journal of clinical medicine · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hemolytic disease of the newborn (HDN), also known as
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.